Detection of early HIV infection and estimation of incidence using a sensitive/less-sensitive enzyme immunoassay testing strategy at anonymous counseling and testing sites in San Francisco

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 22, Issue 5, 1999, Pages 484-489

  McFarland, William ^a,e   Busch, Michael P ^b   Kellogg, Timothy A ^a   Rawal, Bhupat D ^c   Satten, Glen A ^c   Katz, Michael H ^a   Dilley, James ^d   Janssen, Robert S ^c  

^a Department of Public Health ^*  (United States)

^b Blood Centers of the Pacific   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e S Francisco Dept of Public Health   (United States)

Author keywords

Early HIV infection; HIV incidence; HIV testing

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; ENZYME IMMUNOASSAY; FEMALE; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION RATE; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; PRIORITY JOURNAL; SEROCONVERSION; SEROPREVALENCE; SEXUAL BEHAVIOR; STAGING; UNITED STATES;

HUMAN IMMUNODEFICIENCY VIRUS; RNA VIRUSES;

EID: 0033572614     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-199912150-00009     Document Type: Article

References (18)

1. Brookmeyer R, Quinn T, Shepherd M, Mehendale S, Rodrigues J, Bollinger R. The AIDS epidemic in India: a new method for estimating current human immunodeficiency virus (HIV) incidence rates. Am J Epidemiol 1995;142:709-13.
2. Heyward W, Osmanov S, Saba J, et al. Preparation for phase III HIV vaccine efficacy trials: methods for the determination of HIV incidence. AIDS 1994;8:1285-92.
3. Laga M, Alary M, Nzila N, et al. Condom promotion, sexually transmitted diseases treatment, and declining incidence of HIV-1 infection in female Zairian sex workers. Lancet 1994;344:246-8.
4. U.S. Centers for Disease Control and Prevention. National HIV serosurveillance summary: results through 1992, vol 3. Atlanta: US Department of Health and Human Services 1994:1-51.
5. Peterman TA, Zaidi AA, Wroten J. Decreasing prevalence hides a high HIV incidence: Miami. AIDS 1995;9:965-70.
6. McFarland W, Mvere D, Katzenstein D. Risk factors for prevalent and incident HIV infection among volunteer blood donors in Harare, Zimbabwe: implications for blood safety. AIDS 1997;11: S97-S102.
7. Janssen RS, Satten GA, Stramer SL, et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA 1998;280:42-8.
8. Cole KS, Murphey-Corb M, Narayan O, Joag SV, Shaw GM, Montelaro RC. Common themes of antibody maturation to simian immunodeficiency virus, simian-human immunodeficiency virus, and human immunodeficiency virus type 1 infections. J Virol 1998;72:7852-9.
9. McFarland W, Kellogg TA, Dilley J, Katz MH. Estimation of human immunodeficiency virus (HIV) seroincidence among repeat anonymous testers in San Francisco. Am J Epidemiol 1997;146: 662-4.
10. Buchbinder SP, Douglas JM, McKirnan DJ, Judson FN, Katz MH, MacQueen KM. Feasibility of human immunodeficiency virus vaccine trials in homosexual men in the United States: risk behavior, seroincidence, and willingness to participate. J Infect Dis 1996; 8:1285-92.
11. Samuel MC, Hessol N, Shiboski S, Engel RR, Speed TP, Winkelstein W Jr. Factors associated with human immunodeficiency virus seroconversion in homosexual men in three San Francisco cohort studies, 1984-1989. J Acquir Immune Defic Syndr Hum Retroviol 1993;6:303-12.
12. Lemp GF, Hirozawa AM, Givertz D, et al. Seroprevalence of HIV and risk behaviors among young homosexual and bisexual men: the San Francisco/Berkeley Young Men's Survey. JAMA 1994; 272:449-54.
13. Katz MH, McFarland W, Guillin V, et al. Continuing high prevalence of HIV and risk behaviors among young men who have sex with men: the Young Men's Survey in the San Francisco Bay Area in 1992 to 1993 and in 1994 to 1995. J Acquir Immune Defic Syndr Hum Retroviol 1998;19:178-81.
14. Page-Shafer KA, McFarland W, Sheer K, Kohn R, Katz MH, Wohlfeiler D. Increasing HIV risk behavior and sexually transmitted disease rates in the interval of improved efficacy of antiretroviral therapy regimens, San Francisco, 1994-1997. MMWR Morb Mortal Wkly Rep 1999;48:46-8.
15. Ekstrand M, Paul J, Osmond DH. Increasing rates of unprotected anal intercourse among San Francisco gay men include high unprotected anal intercourse rates with a partner of unknown or different serostatus [abstract 23116]. Presented at the XII International Conference on AIDS, Geneva, Switzerland, 1998.
16. Norton J, Elford J, Sherr L, Miller R, Johnson MA. Repeat HIV testers at a London same-day testing clinic. AIDS 1997;11:773-81.
17. McFarland W, Fischer-Ponce L, Katz MH. Repeat negative human immunodeficiency virus (HIV) testing in San Francisco: magnitude and characteristics. Am J Epidemiol 1995;142:719-23.
18. Schwarcz S, Kellogg TA, Kohn RP, Katz MH, Lemp GF, Bolan GA. Temporal trends in human immunodeficiency virus seroprevalence and sexual behavior at the San Francisco municipal sexually transmitted disease clinic, 1989-1992, Am J Epidemiol 1995;142:314-22.